For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Market Overview of Global BioPharmaceutical Tubing market:
According to our latest research, the global BioPharmaceutical Tubing market looks promising in the next 5 years. As of 2022, the global BioPharmaceutical Tubing market was estimated at USD 3225.73 million, and it's anticipated to reach USD 4775.43 million in 2028, with a CAGR of 6.76% during the forecast years.
Biopharmaceutical tubing are specifically designed to meet critical needs of biopharmaceutical and medical industries. This tubing is produced by the extrusion process and is extensively used in drug delivery systems, feeding tubes, and peristaltic pumps as well in a wide range of minimally critical invasive applications, including stent delivery systems, cardiovascular catheters, and urological retrieval devices. Moreover, these are also used with anesthesiology and respiratory equipment, IVs, and biopharmaceutical laboratory equipment. They confer exceptional thermal, mechanical, and chemical properties.
Marketing channel sales will be affected differently
The COVID-19 Outbreak has led to a decline in offline passenger flow, and the advantages of e-commerce companies have become prominent. During the epidemic prevention and control period, some BioPharmaceutical Tubing enterprises did not carry out internet marketing and promotion for their business, so they encountered great resistance in undertaking business. For enterprises that fail to make good use of network promotion means, there is almost no market development during the epidemic period, and the original offline market development plan is disrupted, and the epidemic will face fierce market homogenization competition, which is expected to have a great impact on the company's business throughout the year.
Upstream and downstream interactions will lead to disruption of business
The epidemic will have a short-term impact on BioPharmaceutical Tubing industry, but it is relatively limited. Due to the impact of the epidemic, the production of raw materials and equipment procurement and transportation supply are difficult to be in place, and upstream enterprises affect the work schedule of downstream enterprises. Equipment manufacturing and product manufacturing enterprises in BioPharmaceutical Tubing industry are affected to different degrees, and the production and delivery work may be delayed to some extent. Meanwhile, if it fails to meet the customer's delivery time requirements according to the contract, it may lead to the customer looking for another enterprise and lose business.
Apart from this, the COVID-19 outbreak has resulted in the closing down of several manufacturing facilities across the globe. The pandemic caused huge revenue losses in end-use industry. The coronavirus lockdown put a brake on the production of several key raw materials in the global market, which, in turn, spiked the prices and lowered the demand for the product. The strict lockdown mandates imposed by governments have restricted cross-border trade between countries, another factor proving to be detrimental for the BioPharmaceutical Tubing market share. In addition, BioPharmaceutical Tubing manufacturers are drawing up plans for the international market as a new supply link in the global BioPharmaceutical Tubing industry, as companies look to re-engineer supply chains in the aftermath of COVID-19. Also, it is expected that the product demand in end-user sectors could pick up following the uplift of the lockdown in numerous countries.
Rising Demand for Minimally Invasive Procedures Contributes Significantly to Market Growth
A minimally invasive medical procedure is generally carried out by inserting a small device or an implant in body through an incision or anatomical opening. The popularity of these procedures has increased in the recent years due to the involvement of tiny incisions, faster recovery of patients, and less discomfort caused to the patients. Moreover, these procedures are also associated with benefits such as less trauma to muscles, nerves, tissues, and organs; less bleeding and scarring; and minimal injuries to tissues and less pain.
The growing prevalence of arthritis, cancer, and cardiovascular diseases, all of which require extensive surgical treatments, has boosted demand for minimally invasive procedures. As a result, there is an enormous demand for catheters and biopharmaceutical tubing, among other components. Furthermore, biopharmaceutical tubing systems are reasonably priced and aid in time-saving procedures. For example, employing catheter tubing for cardiac and urine catheterization significantly lowers the time required for the medical or surgical operation. Therefore, the growing demand for minimally invasive medical procedures and focus on increasing the efficiency of these procedures play an important role in propelling the demand for biopharmaceutical tubing.
Stiff competition
The BioPharmaceutical Tubing market is competitive owing to a large number of manufacturers present globally. In order to sustain in the highly competitive market, major players are offering quality products at considerably lower cost. This could result into reduced profits, which is a factor restraining revenue growth of the target market. The presence of numerous players that offers BioPharmaceutical Tubing at lower prices to attract price-sensitive customers poses a significant threat to the market. Despite steady sales, the market for BioPharmaceutical Tubing has failed to achieve its full potential owing to competitive pricing strategies applied by regional players.
With major manufacturers and suppliers in the BioPharmaceutical Tubing industry competing at globally, the intensity of competition within the BioPharmaceutical Tubing industry has increased. The vendors adopt strategies like price premiums to stay competitive in the market. Meanwhile, the local vendors in developing nations are providing tough competition to the global players based on product pricing. The fierce competition is not conducive to the sustainable development of the industry. At the same time, small companies or small retailers enter the business consequently as venturing into a BioPharmaceutical Tubing business does not require immense capital or investment. However, this leads to the proliferation of sub-standard or duplicate products which then hampers the competitive scenario in the market as established BioPharmaceutical Tubing manufacturers are compelled to lower the price of their products, which ultimately impacts their profit margins and sales volumes. The fierce competition is not conducive to the sustainable development of the industry
Region Overview:
Geographically, North America held the largest market share - 39.24% in 2022.
Company Overview:
Saint-Gobain is one of the major players operating in the BioPharmaceutical Tubing market, holding a share of 8.26% in 2023.
Saint-Gobain
Saint-Gobain designs, manufactures and distributes materials and solutions which are key ingredients in the wellbeing of each of us and the future of all. They can be found everywhere in living places and daily life: in buildings, transportation, infrastructure and in so many industrial applications.
Corning
Corning is one of the world's leading innovators in materials science, with a 169-year track record of life-changing inventions. Corning applies its unparalleled expertise in glass science, ceramics science, and optical physics, along with its deep manufacturing and engineering capabilities, to develop category-defining products that transform industries and enhance people's lives.
Segmentation Overview:
Among different product types, Silicone segment is anticipated to contribute the largest market share in 2028.
Application Overview:
The market's largest segment by application is the segment Hospitals & Clinics, with a market share of 45.16% in 2022.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global BioPharmaceutical Tubing market, with a systematical description of the status quo and trends of the whole market, a close look into the competitive landscape of the major players, and a detailed elaboration on segment markets by type, by application and by region.
Key Takeaways from the Global BioPharmaceutical Tubing Market Report:
Market Size Estimates: BioPharmaceutical Tubing market size estimation in terms of value and sales volume from 2018-2028
Market Trends and Dynamics: BioPharmaceutical Tubing market drivers, opportunities, challenges, and risks
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the BioPharmaceutical Tubing market
Segment Market Analysis: BioPharmaceutical Tubing market value and sales volume by type and by application from 2018-2028
Regional Market Analysis: BioPharmaceutical Tubing market situations and prospects in North America, Asia Pacific, Europe, Latin America, Middle East, Africa
Country-level Studies on the BioPharmaceutical Tubing Market: Revenue and sales volume of major countries in each region
BioPharmaceutical Tubing Market Competitive Landscape and Major Players: Analysis of 10-15 leading market players, sales, price, revenue, gross, gross margin, product profile and application, etc.
Trade Flow: Import and export volume of the BioPharmaceutical Tubing market in major regions.
BioPharmaceutical Tubing Industry Value Chain: BioPharmaceutical Tubing market raw materials & suppliers, manufacturing process, distributors, downstream customers
BioPharmaceutical Tubing Industry News, Policies & Regulations
Key players in the global BioPharmaceutical Tubing market are covered in Chapter 12:
Lubrizol Corporation
Corning
SCHOTT AG
Nordson Corporation
WL Gore & Associates
Qure Medical
Teleflex
Zeus Industrial Products
Tekni-Plex
Putnam Plastics
Optinova
RAUMEDIC
DuPont
Freudenberg Group
Saint-Gobain
NewAge Industries, Inc.
In Chapter 2 and Chapter 15.1, based on types, the BioPharmaceutical Tubing market from 2018 to 2028 is primarily split into:
Plastics
Silicone
Glass
Metals
In Chapter 3 and Chapter 15.2, based on applications, the BioPharmaceutical Tubing market from 2018 to 2028 covers:
Hospitals & Clinics,
Ambulatory Surgical Centers
Medical Labs
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 7, 8, 9, 10, 11, 15.3, 15.4:
North America (Covered in Chapter 7)
United States
Canada
Asia-Pacific (Covered in Chapter 8)
China
Japan
India
South Korea
Southeast Asia
Australia
Others
Europe (Covered in Chapter 9)
Germany
France
UK
Italy
Spain
Russia
Poland
Others
Latin America (Covered in Chapter 10)
Mexico
Brazil
Argentina
Others
Middle East and Africa (Covered in Chapter 11)
GCC Countries
Africa
Others
The data of this research report is mainly obtained from industry associations, magazines, press releases, national customs, annual reports of enterprises, expert interviews, paid databases and other channels with authority. It also provides scientific forecasts of the industry's core development indicators through professional analysis and forecasting models.
In short, whatever role you take in this industry value chain, this report will help you or your company to acquire a systematic and in-depth understanding of the industry.
Chapter Outline
This report consists of 16 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 starts the report with an overview of the BioPharmaceutical Tubing market, as well as the definitions of the target market and the subdivisions. Through the presented global market size, regional market sizes, and segment market shares, you will be able to draw an overall and comprehensive picture of the market situation. Meanwhile, the research method and data source will be shared in this chapter.
Chapter 2 and Chapter 3 breaks down the market by different types and applications, with historic data presented in metrics of sales volume, revenue, market share and growth rate.
Chapter 4 elaborates on market dynamics and future trends in the industry, which contains an in-depth analysis of market drivers, opportunities, challenges, and risks. Other essential factors that will have a major impact on the market, i.e., industry news and policies in recent years, global inflation, and regional conflict, are also taken into consideration.
Chapter 5 compares the sales volume and revenue of the major regions across the globe, which enables the readers to understand the regional competitive pattern.
Chapter 6 is the analysis of the trade flow. Import volume and export volume are revealed on a regional level.
Chapters 7-11 focus on country-level studies. Data from the major countries in each region are provided, showing the current development of the industry in different countries. Besides, you will also find qualitative trends analysis under global inflation under each of the 6 regions.
Chapter 12 first up presents the competitive landscape by displaying and comparing the revenues, sales volumes, and market shares of the top players in the market, followed by a company-by-company analysis of all the major market participants with introductions of their products, product applications, company profiles, and business overview. In addition, their competitiveness is manifested through numbers of sales volume, revenue, price, gross and gross margin.
Chapter 13 looks into the whole market industrial chain, ranging from the upstream key raw materials and their suppliers to midstream distributors and downstream customers, with influences of global inflation taken into consideration.
Chapter 14 is perfect for those who wish to develop new projects in the industry. This chapter sheds a light on industry entry barriers and gives suggestions on new project investments.
Chapter 15 forecasts the future trend of the market from the perspective of different types, applications, and major regions.
Chapter 16 is the conclusion of the report which helps the readers sum up the main findings and insights.
Years considered for this report:
Historical Years: 2018-2022
Base Year: 2022
Estimated Year: 2023
Forecast Period: 2023-2028